000 01514 a2200433 4500
005 20250518004929.0
264 0 _c20190610
008 201906s 0 0 eng d
022 _a1525-5069
024 7 _a10.1016/j.yebeh.2018.10.018
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchubert-Bast, Susanne
245 0 0 _aPostmarketing experience with brivaracetam in the treatment of focal epilepsy in children and adolescents.
_h[electronic resource]
260 _bEpilepsy & behavior : E&B
_cDec 2018
300 _a89-93 p.
_bdigital
500 _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAnticonvulsants
_xadverse effects
650 0 4 _aAppetite
_xdrug effects
650 0 4 _aChild
650 0 4 _aChild Behavior Disorders
_xchemically induced
650 0 4 _aChild, Preschool
650 0 4 _aDrug Substitution
_xmethods
650 0 4 _aEpilepsies, Partial
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aPyrrolidinones
_xadverse effects
650 0 4 _aRetrospective Studies
650 0 4 _aSleepiness
700 1 _aWillems, Laurent M
700 1 _aKurlemann, Gerhard
700 1 _aKnake, Susanne
700 1 _aMüller-Schlüter, Karen
700 1 _aRosenow, Felix
700 1 _aStrzelczyk, Adam
773 0 _tEpilepsy & behavior : E&B
_gvol. 89
_gp. 89-93
856 4 0 _uhttps://doi.org/10.1016/j.yebeh.2018.10.018
_zAvailable from publisher's website
999 _c29006866
_d29006866